 |
PDBsum entry 3qpn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3qpn
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
Use of structure-Based design to discover a potent, Selective, In vivo active phosphodiesterase 10a inhibitor lead series for the treatment of schizophrenia.
|
|
|
Authors
|
|
C.J.Helal,
Z.Kang,
X.Hou,
J.Pandit,
T.A.Chappie,
J.M.Humphrey,
E.S.Marr,
K.F.Fennell,
L.K.Chenard,
C.Fox,
C.J.Schmidt,
R.D.Williams,
D.S.Chapin,
J.Siuciak,
L.Lebel,
F.Menniti,
J.Cianfrogna,
K.R.Fonseca,
F.R.Nelson,
R.O'Connor,
M.Macdougall,
L.Mcdowell,
S.Liras.
|
|
|
Ref.
|
|
J Med Chem, 2011,
54,
4536-4547.
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
